Royce Small-Cap Trust Files Annual Proxy Statement

TL;DR

Royce Small-Cap Trust filed its DEF 14A. Annual shareholder meeting info.

AI Summary

Royce Small-Cap Trust, Inc. filed its definitive proxy statement on August 8, 2024, for the fiscal year ending December 31, 2024. The filing, designated as DEF 14A, outlines information required for their proxy statement, indicating it's a routine annual disclosure. The company's principal executive offices are located at 745 Fifth Avenue, New York, NY.

Why It Matters

This filing is a standard annual disclosure that provides shareholders with essential information regarding the company's governance, executive compensation, and voting matters for the upcoming annual meeting.

Risk Assessment

Risk Level: low — This is a routine annual filing (DEF 14A) for a publicly traded investment trust, not indicating any unusual events or financial distress.

Key Numbers

• 1231 — Fiscal Year End (Indicates the end of the reporting period for financial statements.)

Key Players & Entities

• ROYCE SMALL-CAP TRUST, INC. (company) — Registrant
• 745 FIFTH AVENUE (location) — Business Address
• New York, NY (location) — Business Address City/State
• August 8, 2024 (date) — Filing Date

FAQ

Filing Documents

• g102523_rvt.htm (DEF 14A) — 234KB
• img011_v2.jpg (GRAPHIC) — 147KB
• img012_v2.jpg (GRAPHIC) — 218KB
• img009_v2.jpg (GRAPHIC) — 375KB
• img010_v2.jpg (GRAPHIC) — 176KB
• 0000949377-24-000115.txt ( ) — 1484KB

financial statements; (b) independent accountants’ qualifications and independence; and (c) performance of the

financial statements; (b) independent accountants’ qualifications and independence; and (c) performance of the Fund’s independent accountants and (ii) prepare, or oversee the preparation of any audit committee report required by rules of the SEC to be included in the Fund’s proxy statement for its annual meeting of stockholders. The Board has adopted an Audit Committee charter for the Fund, a copy of which was included as an exhibit to the Proxy Statement for the Fund’s 2022 Annual Meeting of Stockholders. A copy of the Audit Committee charter for the Fund may be obtained by calling 1-800-221-4268. 9 The Audit Committee also has (i) received written disclosures and the letter required by Independence Standards Board Standard No. 1 from PricewaterhouseCoopers LLP (“PWC”), the Fund’s independent auditors for the fiscal year ended December 31, 2023, and (ii) discussed certain matters required to be discussed under the requirements of The Public Company Accounting Oversight Board with PWC. The Audit Committee has considered whether the provision of non-audit services by the Fund’s independent accountants is compatible with maintaining their independence. At its meeting held on February 16, 2024, the Audit Committee reviewed and discussed the audit of the Fund’s financial statements as of December 31, 2023, and for the fiscal year then ended with Fund management and PWC. Had any material concerns arisen during the course of the audit and the preparation of the audited financial statements mailed to stockholders and included in the Fund’s 2023 Annual Report to Stockholders, the Audit Committee would have been notified by Fund management or PWC. The Audit Committee received no such notifications. At those meetings, the Audit Committee recommended to the Board that the Fund’s audited

financial statements be included in the Fund’s 2023 Annual Report to Stockholders

financial statements be included in the Fund’s 2023 Annual Report to Stockholders. Nominating Committee The Board has a Nominating Committee (the “Nominating Committee”) composed of the six Independent Directors, namely Ms. Chadwick, Ms. Harper, and Ms. Poston, and Messrs. Grisanti, O’Brien, and Shields. Mr. O’Brien currently serves as the Chair of the Nominating Committee. The Board has adopted a Nominating Committee charter for the Fund, a copy of which was included as an exhibit to the Proxy Statement for the Fund’s 2022 Annual Meeting of Stockholders. A copy of the Nominating Committee charter for the Fund may be obtained by calling 1-800-221-4268 . The Nominating Committee is responsible for identifying and recommending to the Board individuals believed to be qualified to become Board members in the event that a position is vacated or created. The Nominating Committee will consider Director candidates recommended by stockholders. In considering potential nominees, the Nominating Committee will take into consideration (i) the contribution which the person can make to the Board, with consideration given to the person’s business and professional experience, education and such other factors as the Committee may consider relevant, including but not limited to whether a potential nominee’s personal and professional qualities and attributes would provide a beneficial diversity of skills, experience and/or perspective to the Board; (ii) the character and integrity of the person; (iii) whether or not the person is an “interested person” as defined in the Investment Company Act and whether the person is otherwise qualified under applicable laws and regulations to serve as a Director or Independent Director of the Fund; (iv) whether or not the person has any relationships that might impair his or her independence, such as any business, financial or family relationships with Fund management, the investment a

View Full Filing

View this DEF 14A filing on SEC EDGAR